Cargando…
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
As solid organ transplant recipients are at high risk of severe COVID-19 and respond poorly to primary SARS-CoV-2 mRNA vaccination, they have been prioritized for booster vaccination. However, an immunological correlate of protection has not been identified in this vulnerable population. We conducte...
Autores principales: | Kemlin, Delphine, Gemander, Nicolas, Depickère, Stéphanie, Olislagers, Véronique, Georges, Daphnée, Waegemans, Alexandra, Pannus, Pieter, Lemy, Anne, Goossens, Maria E., Desombere, Isabelle, Michiels, Johan, Vandevenne, Marylène, Heyndrickx, Leo, Ariën, Kevin K., Matagne, André, Ackerman, Margaret E., Le Moine, Alain, Marchant, Arnaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911984/ https://www.ncbi.nlm.nih.gov/pubmed/36773936 http://dx.doi.org/10.1016/j.ajt.2023.02.015 |
Ejemplares similares
-
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
por: Pannus, Pieter, et al.
Publicado: (2023) -
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
por: Pannus, Pieter, et al.
Publicado: (2022) -
Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection
por: Tomasi, Lisa, et al.
Publicado: (2022) -
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
por: Baron, Frédéric, et al.
Publicado: (2022) -
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients
por: Canti, Lorenzo, et al.
Publicado: (2022)